DE69915514D1 - Prenyltransferase-inhibitoren - Google Patents

Prenyltransferase-inhibitoren

Info

Publication number
DE69915514D1
DE69915514D1 DE69915514T DE69915514T DE69915514D1 DE 69915514 D1 DE69915514 D1 DE 69915514D1 DE 69915514 T DE69915514 T DE 69915514T DE 69915514 T DE69915514 T DE 69915514T DE 69915514 D1 DE69915514 D1 DE 69915514D1
Authority
DE
Germany
Prior art keywords
prenyl
chem
inhibitors
bond
chr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69915514T
Other languages
English (en)
Other versions
DE69915514T2 (de
Inventor
D Gordon
A Morgan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS filed Critical Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Application granted granted Critical
Publication of DE69915514D1 publication Critical patent/DE69915514D1/de
Publication of DE69915514T2 publication Critical patent/DE69915514T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69915514T 1998-12-31 1999-12-30 Prenyltransferase-inhibitoren Expired - Lifetime DE69915514T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US224428 1994-04-08
US22442898A 1998-12-31 1998-12-31
US11430198P 1998-12-31 1998-12-31
US114301P 1998-12-31
PCT/US1999/031302 WO2000039130A2 (en) 1998-12-31 1999-12-30 Prenyl transferase inhibitors

Publications (2)

Publication Number Publication Date
DE69915514D1 true DE69915514D1 (de) 2004-04-15
DE69915514T2 DE69915514T2 (de) 2005-01-05

Family

ID=26812031

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69941307T Expired - Lifetime DE69941307D1 (de) 1998-12-31 1999-12-30 Prenyl transferasinhibitoren
DE69915514T Expired - Lifetime DE69915514T2 (de) 1998-12-31 1999-12-30 Prenyltransferase-inhibitoren

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69941307T Expired - Lifetime DE69941307D1 (de) 1998-12-31 1999-12-30 Prenyl transferasinhibitoren

Country Status (14)

Country Link
US (2) US7361656B2 (de)
EP (2) EP1140942B1 (de)
AT (2) ATE261447T1 (de)
AU (1) AU2717100A (de)
CA (1) CA2356756A1 (de)
CZ (1) CZ20012358A3 (de)
DE (2) DE69941307D1 (de)
DK (1) DK1140942T3 (de)
ES (2) ES2328564T3 (de)
HU (1) HUP0104708A3 (de)
NO (1) NO321057B1 (de)
PT (1) PT1140942E (de)
RU (1) RU2241712C9 (de)
WO (1) WO2000039130A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2812546B1 (fr) * 2000-08-01 2008-11-21 Sod Conseils Rech Applic Derives d'heterocycles a 5 chainons, leur preparation et leur application a titre de medicaments
TWI283577B (en) * 1999-10-11 2007-07-11 Sod Conseils Rech Applic Pharmaceutical composition of imidazole derivatives acting as modulators of sodium channels and the use thereof
WO2004028541A2 (en) * 2002-09-27 2004-04-08 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Composition for the treatment of nasopharyngeal carcinoma and use thereof
ES2546815T3 (es) * 2006-12-15 2015-09-28 Bristol-Myers Squibb Company Análogos de arilpropilamida, arilacrilamida, arilpropinamida o arilmetilurea como inhibidores del factor XIa
JO3156B1 (ar) 2009-07-09 2017-09-20 Novartis Ag ايميدازولات مدمجة والتركيبات التي تشملها لعلاج الأمراض الطفيلية على مثال الملاريا
EP2508511A1 (de) 2011-04-07 2012-10-10 Laboratoire Biodim Inhibitoren der Virenreplikation, Verfahren zu deren Herstellung und deren therapeutische Verwendung
BR112015012366A8 (pt) * 2012-11-29 2019-10-01 Chemocentryx Inc antagonistas de cxcr7, uso dos mesmos, composição farmacêutica, bem como métodos para detectar níveis elevados de cxcr7 em uma amostra e para imagear um tumor, órgão, ou tecido
CN106317057B (zh) * 2015-07-02 2019-02-01 北京桦冠医药科技有限公司 具有咪唑并吡嗪类衍生物，其制备及其在医药上的应用
CN110691597A (zh) 2017-04-24 2020-01-14 诺华股份有限公司 2-氨基-1-(2-(4-氟苯基)-3-(4-氟苯基氨基)-8,8-二甲基-5,6-二氢咪唑并[1,2-a]吡嗪-7(8H)-基)乙酮及其组合的治疗方案

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5488109A (en) 1993-11-05 1996-01-30 Dowelanco 5-alkoxy[1,2,4]triazolo[1,5-c]pyrimidine-2(3H)--thione compounds and their use in the preparation of and 2-chlorosulfonyl-5-alkoxy[1,2,4]triazolo[1,5-c]-pyrimidine compounds
US5488189A (en) * 1993-12-14 1996-01-30 E. I. Du Pont De Nemours And Company Process for fluorinated propanes and pentanes
US6673927B2 (en) * 1996-02-16 2004-01-06 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Farnesyl transferase inhibitors
FR2780974B1 (fr) * 1998-07-08 2001-09-28 Sod Conseils Rech Applic Utilisation de derives d'imidazopyrazines pour preparer un medicament destine a traiter les pathologies qui resultent de la formation de la proteine g heterotrimetrique
UA74912C2 (en) * 2001-07-06 2006-02-15 Merck & Co Inc Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes

Also Published As

Publication number Publication date
US7691859B2 (en) 2010-04-06
EP1382607A3 (de) 2004-06-30
DE69941307D1 (de) 2009-10-01
ATE261447T1 (de) 2004-03-15
US20060142275A1 (en) 2006-06-29
RU2241712C9 (ru) 2006-04-20
DK1140942T3 (da) 2004-05-24
EP1140942A2 (de) 2001-10-10
ES2215420T3 (es) 2004-10-01
NO321057B1 (no) 2006-03-06
AU2717100A (en) 2000-07-31
DE69915514T2 (de) 2005-01-05
EP1382607B1 (de) 2009-08-19
ATE440100T1 (de) 2009-09-15
WO2000039130A3 (en) 2000-11-02
NO20013281D0 (no) 2001-06-29
EP1382607A2 (de) 2004-01-21
US20080176835A1 (en) 2008-07-24
HUP0104708A3 (en) 2004-05-28
CA2356756A1 (en) 2000-07-06
HUP0104708A2 (hu) 2002-04-29
US7361656B2 (en) 2008-04-22
EP1140942B1 (de) 2004-03-10
WO2000039130A2 (en) 2000-07-06
NO20013281L (no) 2001-08-29
ES2328564T3 (es) 2009-11-16
CZ20012358A3 (cs) 2002-01-16
RU2241712C2 (ru) 2004-12-10
PT1140942E (pt) 2004-05-31

Similar Documents

Publication Publication Date Title
PT976748E (pt) Derivados de pirrolidina com actividade inibidora de fosfolipase a2
DK0931788T3 (da) Metalloproteasehæmmere
DK1022272T3 (da) Substituerede, fusionerede, heterocykliske forbindelser
DE69915004D1 (de) 5-Oxo-pyrrolidine-2-Carbonsäure-Hydroxamidderivate
MY136141A (en) Novel hydantoin derivatives and pharmaceutical compositions useful as metalloproteinase inhibitors
GB9625045D0 (en) Parasiticidal compounds
DK1265606T3 (da) Celleadhæsionsinhibitorer
DE60141815D1 (de) Reagentien zur bestimmung des aktiven sauerstoffs
AU7517400A (en) N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
PT918776E (pt) Sintese total de acilfulvenos antitumorais
DK0791007T3 (da) Antifungale sordaridinderivater
ATE440100T1 (de) Prenyl transferasinhibitoren
ATE232528T1 (de) Pyrimidinylpyrazolderivate
BR0101556A (pt) Composto heterocìclico

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: UEXKUELL & STOLBERG, 22607 HAMBURG

8327 Change in the person/name/address of the patent owner

Owner name: IPSEN PHARMA S.A.S., BOULOGNE-BILLANCOURT, FR